6-三氟甲基吲哚 | 13544-43-9

• 物质功能分类: 医药中间体 - 吲哚类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 6-三氟甲基吲哚
• 中文别名: 6-(三氟甲基)吲哚
• 英文名称: 6-(trifluoromethyl)-1H-indole
• 英文别名: 6-trifluoromethylindole；6-(Trifluoromethyl)indole
• CAS: 13544-43-9
• 化学式: C₉H₆F₃N
• mdl: MFCD00272316
• 分子量: 185.149
• InChiKey: BPYBYPREOVLFED-UHFFFAOYSA-N

物化性质

• 熔点：
  101 °C
• 沸点：
  109-110 °C
• 密度：
  1.367±0.06 g/cm3(Predicted)
• 稳定性/保质期：

  在常温常压下稳定，应避免氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  15.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R22,R36/37/38
• 海关编码：
  2933990090
• 包装等级：
  III
• 危险品运输编号：
  2811
• 危险性防范说明：
  P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
6-Trifluoromethylindole
Product Name:
Synonyms: 6-(Trifluoromethyl)-1H-indole

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
6-Trifluoromethylindole
Ingredient name:
CAS number: 13544-43-9

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H6F3N
Molecular weight: 185.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  6-三氟甲基吲哚 在 palladium on activated charcoal 盐酸 、 氢氧化钾 、 氢气 作用下， 以 甲醇 为溶剂， 70.0 ℃ 、300.0 kPa 条件下， 反应 6.0h， 生成 3-(piperidin-4-yl)-6-(trifluoromethyl)-1H-indole
  参考文献：
  名称：

  新型组胺H1拮抗剂：吲哚基哌啶基苯甲酸衍生物的合成与构效关系。

  摘要：

  制备了一系列的吲哚基哌啶基衍生物，并对其作为组胺H（1）拮抗剂的活性进行了评估。结构-活性关系研究旨在提高我们的第一个前导分子的体内活性和药代动力学特征（1）。吲哚环上位置6上的氟取代在抑制组胺诱导的皮肤血管通透性测定中导致较高的体内活性，但对5HT（2）受体的选择性较低。在该系列中进行了广泛的优化，并鉴定了许多组胺H（1）拮抗剂，这些拮抗剂在体内具有强大的作用力和作用时间长，脑渗透力低或具有心脏毒性的潜力。在这个新系列中，吲哚基哌啶15、20、48、51和52在大鼠中显示出长的半衰期，并已被选择用于进一步的临床前评估。

  DOI：

  10.1021/jm0498203
• 作为产物：
  描述：

  2-溴-5-三氟甲苯苯胺 在 bis-triphenylphosphine-palladium(II) chloride 吡啶 、 copper(l) iodide 、 sodium ethanolate 、 三乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 7.5h， 生成 6-三氟甲基吲哚
  参考文献：
  名称：

  Synthesis of N-Aminoindole Ureas from Ethyl 1-Amino-6-(trifluoromethyl)-1H-indole-3-carboxylate

  摘要：

  本文介绍了合成 6-(三氟甲基)-1H-吲哚-3-羧酸乙酯的两条途径。以吡啶为溶剂，将该关键中间体与 O-(二苯基膦酰基)羟胺进行 N-胺化，然后与芳基异氰酸酯反应，得到相应的 N-氨基吲哚脲 1-4，收率良好。

  DOI：

  10.1055/s-2001-10784

文献信息

• A general N-alkylation platform via copper metallaphotoredox and silyl radical activation of alkyl halides
  作者：Nathan W. Dow、Albert Cabré、David W.C. MacMillan

  DOI：10.1016/j.chempr.2021.05.005

  日期：2021.7

  The catalytic union of amides, sulfonamides, anilines, imines, or N-heterocycles with a broad spectrum of electronically and sterically diverse alkyl bromides has been achieved via a visible-light-induced metallaphotoredox platform. The use of a halogen abstraction-radical capture (HARC) mechanism allows for room temperature coupling of C(sp3)-bromides using simple Cu(II) salts, effectively bypassing

  通过可见光诱导的金属光氧化还原平台实现了酰胺、磺胺、苯胺、亚胺或N-杂环与广谱电子和空间多样化烷基溴的催化结合。卤素提取-自由基捕获 (HARC) 机制的使用允许使用简单的 Cu(II) 盐在室温下耦合 C( sp 3 )-溴化物，有效绕过通常与热诱导 S N 2 或 S相关的过高障碍N 1 N-烷基化。这种区域和化学选择性方案与 >10 类药物相关的N兼容- 亲核试剂，包括已建立的药剂，以及结构多样的伯、仲和叔烷基溴。此外，通过将N-亲核试剂与环丙基溴和未活化的烷基氯（与亲核取代途径不相容的底物）结合，突出了 HARC 方法与传统惰性偶联伙伴结合的能力。初步的机械实验验证了该平台的双重催化、开壳性质，这使得在传统的基于卤化物的N-烷基化系统中无法实现的反应性成为可能。
• Access to Branched Allylarenes via Rhodium(III)-Catalyzed C–H Allylation of (Hetero)arenes with 2-Methylidenetrimethylene Carbonate
  作者：Shang-Shi Zhang、Yi-Chuan Zheng、Zi-Wu Zhang、Shao-Yong Chen、Hui Xie、Bing Shu、Jia-Lin Song、Yan-Zhi Liu、Yao-Fu Zeng、Luyong Zhang

  DOI：10.1021/acs.orglett.1c01832

  日期：2021.8.6

  A rhodium(III)-catalyzed C–H allylation of (hetero)arenes by using 2-methylidenetrimethylene carbonate as an efficient allylic source has been developed for the first time. Five different directing groups including oxime, N-nitroso, purine, pyridine, and pyrimidine were compatible, delivering various branched allylarenes bearing an allylic hydroxyl group in moderate to excellent yields.

  首次开发了使用 2-亚甲基亚甲基碳酸酯作为有效烯丙基来源的铑（III）催化（杂）芳烃的 C-H 烯丙基化反应。五种不同的导向基团包括肟、N-亚硝基、嘌呤、吡啶和嘧啶是相容的，以中等至极好的产率提供带有烯丙基羟基的各种支链烯丙基芳烃。
• Compounds having effects on serotonin-related systems
  申请人：Eli Lilly and Company

  公开号：US05741789A1

  公开（公告）日：1998-04-21

  A series of hetero-oxy alkanamines are effective pharmaceuticals for the treatment of conditions related to or affected by the reuptake of serotonin and by the serotonin 1.sub.A receptor. The compounds are particularly useful for alleviating the symptoms of nicotine and tobacco withdrawal, and for the treatment of depression and other conditions for which serotonin reuptake inhibitors are used.

  一系列的杂氧烷胺类化合物是治疗与血清素再摄取和血清素1A受体有关或受其影响的疾病的有效药物。这些化合物特别适用于缓解尼古丁和烟草戒断症状，以及治疗抑郁症和其他需要使用血清素再摄取抑制剂的疾病。
• Indium(III) Catalyzed Reactions of Vinyl Azides and Indoles
  作者：Atul A. More、Alex M. Szpilman

  DOI：10.1021/acs.orglett.0c00919

  日期：2020.5.15

  Indium trichloride catalyzes the reaction of vinyl azides with unfunctionalized indoles to give vinyl indoles. This is the first example of displacement of the azide group by a carbon nucleophile while preserving the vinyl function. The protocol employs very mild reaction conditions and offers excellent yields of diverse 3-vinyl indoles. It is amenable to gram scale. Access to a library of 3,3'-bis(indolyl)methanes

  三氯化铟催化叠氮化乙烯与未官能化的吲哚的反应，生成乙烯基吲哚。这是在保持乙烯基官能的同时，碳亲核试剂取代叠氮化物基团的第一个例子。该方案采用非常温和的反应条件，并提供了各种3-乙烯基吲哚的优异收率。它适合克规模。展示了通过叠氮化乙烯基酯与2当量吲哚的缩合获得3,3'-双（吲哚基）甲烷的文库。
• NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
  申请人：INVENTIVA

  公开号：US20170066717A1

  公开（公告）日：2017-03-09

  The invention relates to compounds of formula (I). where R, R 1 , R 2 , n, A and Cy have the meanings indicated in the description. The compounds of formula (I) are Nurr-1 modulators.

  这项发明涉及式(I)的化合物。 其中R、R1、R2、n、A和Cy的含义如描述中所示。 式(I)的化合物是Nurr-1调节剂。